Log in  First Connection?

Atopic Dermatitis: Archives News of the month

Incidence of Conjunctivitis and Keratitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States: a Cohort Study in Routine Care Based on Healthcare Claims

 Published on 24/03/2025 |  Original article (Abstract)  | Jessica M. Franklin   et al. | Dermatology and therapy 2025; 15(4): 889-901

Atopic dermatitis (AD) is a common chronic inflammatory skin condition characterized by pruritis and skin lesions [1]. The estimated overall prevalence of AD in US adults is 10.2%, of which approximately 40% can be classified as moderate to severe [2]. AD affects quality of life and has psychological...

The APOLO Study: A Cross-Sectional Analysis of Disease Characteristics and Patient Burden in Moderate-to-Severe Atopic Dermatitis in Portugal

 Published on 17/03/2025 |  Original article (Abstract)  | Bruno Duarte et al. | Dermatology and therapy 2025; 15(3): 647-62

Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease, with a lifelong prevalence of up to 20% in developed countries [1]. The prevalence of AD varies with geographic region, affecting around 20% of children and up to 10% of adults [2,3,4]. AD typically manifests within the first...

Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open‐labeled single‐blinded randomized controlled trial

 Published on 10/03/2025 |  Original article (Abstract)  | Disha Chakraborty et al. | International Journal of Dermatology 2024; AOP: 10.1111/ijd.17572

Atopic dermatitis (AD) is a chronic inflammatory skin condition marked by pruritic eczematous lesions that can significantly affect quality of life. Most cases are mild to moderate, for which guidelines recommend topical therapies like calcineurin inhibitors, corticosteroids, and emollients. Topical...

Genetic landscape of atopic dermatitis

 Published on 03/03/2025 |  Original article (Abstract)  | Paternoster et al. | Current Opinion in Allergy and Clinical Immunology 2024; 24(5): 409-15

It has long been known that atopic dermatitis is highly heritable [1]. Since FLG was the first gene implicated for atopic dermatitis, the past 15 years has seen advances in genotyping technology and Biobank data collection, which has resulted in studies identifying many genomic loci associated...

Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review

 Published on 24/02/2025 |  Original article (Abstract)  | Tiago Torres   et al. | Dermatology and therapy 2025; 15(3): 579-97

Atopic dermatitis (AD), also known as atopic eczema, is a chronic inflammatory skin disease that causes intense itching and recurrent eczematous lesions [1]. Characterized by debilitating signs and symptoms—intense itching (pruritus), eczematous lesions, and impaired skin barrier—AD disrupts...